Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Escalating Malaria Cases and Prevalence of Rheumatoid Arthritis in Massive Numbers to Sow the Seeds of Growth across Hydroxychloroquine Drugs Market between 2020 and 2030: TMR

      This image opens in the lightbox

      News provided by

      Transparency Market Research

      16 Jun, 2021, 14:30 GMT

      Share this article

      Share this article


      - Overwhelming use in treating a number of diseases and disorders may serve as a prominent growth-contributing factor for the hydroxychloroquine drugs market during the assessment period of 2020-2030.

      - The global hydroxychloroquine drugs market is anticipated to expand at a CAGR of 10 percent across the assessment period of 2020-2030

      ALBANY, N.Y., June 16, 2021 /PRNewswire/ -- The lifestyle changes in a large number of individuals coupled with the growing threat of malaria will serve as pillars of growth for the hydroxychloroquine drugs market during the tenure of 2020-2030. According to the World Health Organization (WHO), nearly 229 mn cases of malaria were recorded in 2019. The number of deaths that occurred due to malaria stood at 409000. These alarming statistics provide an insight into the escalating threat of malaria. Thus, all these factors prove fruitful for the growth of the hydroxychloroquine drugs market.

      Hydroxychloroquine drugs are types of oral medications. These medications are used for treating autoimmune diseases such as rheumatoid arthritis and others. The main function of hydroxychloroquine drugs lies in treating malaria. The United States Center for Disease Control recently upgraded its guidelines in terms of the use of hydroxychloroquine drugs in treating and preventing malaria. The updated guidelines recommend the use of hydroxychloroquine for treating malaria. All these aspects join the dots of growth across the hydroxychloroquine drugs market.

      Request for Analysis of COVID-19 Impact on Hydroxychloroquine Drugs Market – https://www.transparencymarketresearch.com/covid19.php

      The Transparency Market Research (TMR) team has conducted intensive research on various aspects related to the growth of the hydroxychloroquine drugs market. Every point is analyzed, verified, and rechecked thoroughly. The projections made by the TMR team predict that the global hydroxychloroquine drugs market will record a CAGR of 10 percent across the assessment period of 2020-2030. The global hydroxychloroquine drugs market stood at US$ 0.67 bn in 2019.

      The utilization of hydroxychloroquine drugs to tackle diverse diseases and disorders will add extra stars of growth. Furthermore, the swelling production and demand on the back of the findings suggesting the efficacy of hydroxychloroquine in reducing the effect of COVID-19 in the body led to a rapid boost in the growth prospects. Thus, all these factors proved to be great growth generators for the hydroxychloroquine drugs market.

      Request Brochure of Hydroxychloroquine Drugs Market Report - https://www.transparencymarketresearch.com/brochure.php

      Hydroxychloroquine Drugs Market: Analysts' View

      The TMR analysts highlight the rising incidences of juvenile idiopathic arthritis and the extensive prevalence of lupus as the prominent growth-generating factors for the hydroxychloroquine drugs market. The analysts further highlight the drug resistance issue faced by numerous healthcare professionals. To tackle this issue, pharmaceutical companies are designing mapping tools and data visualization.

      Key Findings of the Report

      Short-lived Fame of Hydroxychloroquine for Use in COVID-19 Recovery Led to Skyrocketing Demand

      As the novel coronavirus pandemic struck last year across the globe, many research and studies were conducted. Various treatment options were being studied. One of the studies found hydroxychloroquine to be effective in the recovery of COVID-19. Following this study, many countries gave emergency approvals to hydroxychloroquine for use in COVID-19 patients.

      Purchase the Hydroxychloroquine Drugs Market Report - https://www.transparencymarketresearch.com/checkout.php

      The demand and production of hydroxychloroquine increased exponentially after the approvals. Though later hydroxychloroquine was regarded ineffective in recovering from COVID-19, the growth observed during the short-lived fame boosted the growth rate of the hydroxychloroquine drugs market intensively.

      Growing Cases of Malaria and Rheumatoid Arthritis to Accelerate Growth Prospects

      The rising cases of malaria among a considerable chunk of the populace may invite tremendous growth opportunities for the hydroxychloroquine drugs market. Furthermore, the escalating geriatric population may bring intensive growth prospects as arthritis is more common among their age group. Thus, all these factors will invite promising growth for the hydroxychloroquine drugs market.

      Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

      Rheumatoid Arthritis Drugs Market: https://www.transparencymarketresearch.com/rheumatoid-arthritis-drugs.html

      Macular Degeneration Treatment Market: https://www.transparencymarketresearch.com/macular-degeneration-treatment-market.html

      About Us

      Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

      Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

      TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

      TMR's Latest News Publication - https://www.medgadget.com/2021/06/electronic-health-records-market-high-prevalence-and-increase-in-incidences-of-diseases-amongst-patients-to-drive-the-market.html

      Contact

      Mr. Rohit Bhisey
      Transparency Market Research
      State Tower,
      90 State Street,
      Suite 700,
      Albany NY - 12207
      United States
      USA - Canada Toll Free: 866-552-3453
      Email: sales@transparencymarketresearch.com 
      Press Release Source: https://www.transparencymarketresearch.com/pressrelease/hydroxychloroquine-drugs-market.htm 
      Website: https://www.transparencymarketresearch.com/

      Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.